View in EDS

Efficacy and safety of etifoxine versus alprazolam in generalized anxiety disorders with somatic symptoms: A randomized, double-blind, comparative study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of etifoxine versus alprazolam in generalized anxiety disorders with somatic symptoms: A randomized, double-blind, comparative study.
Authors: Prabhakar K; Department of Psychiatry, Medipoint Hospital Pvt. Ltd, Maharashtra, India., Ganesan G; Department of Psychiatry, Medstar Speciality Hospital, Karnataka, India., Chaudhari D; Department of Psychiatry, GSVM Medical College, Uttar Pradesh, India., Dalaya N; Clinical Research Department, Lifepoint Multispeciality Hospital, Maharashtra, India., Mohide A; Department of Psychiatry, Ishwar Institute of health care, Maharashtra, India., Thaker S; Department of Psychiatry, Shivam Hospital, Gujarat, India., Dutta M; Department of Psychiatry, Om Hospital, Chhattisgarh, India., Patil B; Department of Psychology, Priyadarshani nursing home, Maharashtra, India., Mukhopadhyay A; Department of Psychiatry, Nil Ratan Sircar medical college & Hospital, West Bengal, India., Neeli UJ; Department of Psychiatry, Government General Hospital, Andhra Pradesh, India., Kumar A; Department of Psychiatry, S.N Medical College, Uttar Pradesh, India., Rajendra R; Department of Psychiatry, Mysore Medical College and Research Institute and Krishna Rajendra Hospital, Karnataka, India., Shaikh R; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Saha S; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Sonowal S; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India. Electronic address: Supriya.sonowal1@sunpharma.com., Behera S; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Devkare P; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Pandit S; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Patil D; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Ghadge P; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Lakhwani L; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Mehta S; Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Maharashtra, India., Joglekar S; Medical Affairs, Sun Pharmaceutical Industries Limited, Maharashtra, India.
Source: Journal of anxiety disorders [J Anxiety Disord] 2026 Apr; Vol. 119, pp. 103147. Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study; Clinical Trial, Phase III
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8710131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7897 (Electronic) Linking ISSN: 08876185 NLM ISO Abbreviation: J Anxiety Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7897
DOI:10.1016/j.janxdis.2026.103147